Jun 12, 2020
EHA25Virtual: Gut Microbiome Disturbance by Antibiotic Treatment Early in Life is Sufficient to Induce Leukemia in Predisposed Mice
Apr 14, 2020
AVM Biotechnology has FDA Approval for Clinical Trials for Promising New Cancer Treatment
Mar 24, 2020
2020 B-Cell Chronic Lymphocytic Leukemia Pipeline Assessment: Therapeutics, Drugs, Companies, Developments
Feb 27, 2020
Chronic Lymphocytic Leukemia Market, Forecast to 2025 - Roche, AstraZeneca, Verastem, Novartis, and AbbVie are Dominating
Jan 27, 2020
Global B-cell Non-Hodgkin's Lymphoma Market Review 2017-2019 and Forecast 2020-2028
Aug 06, 2019
Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
Jul 12, 2019
U.S. Lymphocytic Leukemia Market Analysis 2014-2018 & Forecast 2019-2024
Jul 02, 2019
Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market to Reach $3.52 Bn, Globally, by 2026 at 5.3% CAGR: Allied Market Research
Apr 24, 2019
Chronic Lymphocytic Leukemia Market (CLL) - Epidemiology, 7 MM Insight, Diagnosis and Treatment Patterns and Forecast to 2028
Aug 13, 2018
Chronic Lymphocytic Leukemia (CLL) Market Insights, Epidemiology and Market Forecast to 2027
Jun 14, 2018
Global CAR T Cell Therapy Market 2016-2026: The Most Hot Topic Discussed Among Oncologists Throughout the Globe
May 31, 2018
Lymphocytic Leukemia Pipeline Market (ALL) 2018 Analysis, Therapeutics and Drug Research Report
Apr 06, 2018
BESPONSA(TM) Approved by Health Canada for the Treatment of Adults with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Dec 01, 2017
B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Oct 30, 2017
Janssen Inc. Announces IMBRUVICA® (ibrutinib) as the First Approved Treatment for Chronic Graft-Versus-Host Disease (cGVHD) Granted by Health Canada Priority Review
Jun 19, 2017
LLS Community Helps Blood Cancer Patients and Caregivers Find Online Support and Cutting-Edge Health Information
Jun 15, 2017
Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic Leukemia Research